TREM2 has been intensively studied in the context of neurodegenerative diseases, revealing its concurrent role in engulfment of Aβ-amyloid plaques and sustainment of cellular energetic and biosynthetic metabolism during Alzheimer’s disease [9]. The gene discussed is TREM2; the disease is early-onset autosomal dominant Alzheimer disease.